Recent news on Colesevelam Hydrochloride

KineMed Evaluates the Mechanism of Action for Colesevelam in ...  -  May 21, 2007
Earthtimes.org...double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.

Cholesterol-Lowering Drug Combined With Metformin Improves Glucose ...  -  Apr 16, 2007
DG NewsSEATTLE, WA -- April 16, 2007 -- When colesevelam hydrochloride -- a bile acid sequestrant designed to reduce cholesterol levels -- was added to the

Genzyme Reports Strong Fourth-Quarter Revenue Growth to Conclude ...  -  Jan 10, 2007
Oxfordshire Bioscience Network (press release),...sale of WelChol® (colesevelam hydrochloride)-was $44 million in the fourth quarter, 19 percent greater than $37 million in the same quarter last year.

Genzyme Reports Strong Third-Quarter Financial Results  Oct 12, 2006
...revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride) -- was $38.1 ... -Yahoo! News (press release) Genzyme Reports Strong Third-Quarter Financial Results  Oct 12, 2006
...revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- was $38.1 ... -Drug Newswire (press release), Study of Tolevamer for C. difficile-Associated Diarrhea Published ...  Aug 16, 2006
...sevelamer hydrochloride) controls serum phosphorus in patients with chronic kidney disease on dialysis, and WelChol(R) (colesevelam hydrochloride) reduces LDL ... -DG News

Delivers Solid Earnings Growth Based on Strong Top-Line ...  Jul 18, 2006
Other revenue-including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride)-increased 30 ... -Oxfordshire Bioscience Network

Genzyme Reports Second-Quarter Financial Results  Jul 12, 2006
...including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- increased 30 percent ... -Drug Newswire

1st Clinical Trial To Show Colesevelam HCl Plus Stable Oral ...  Jun 26, 2006
The first data to demonstrate the effect of WelChol® (colesevelam hydrochloride) on glucose lowering was presented today at The American Diabetes ... -Medical News Today



Addition Of A Bile Acid Sequestrant (WelChol, Colesevelam HCl) To ...  Apr 19, 2006
Data published today in the April 15 issue of the American Journal of Cardiology demonstrated that adding WelChol(R) (colesevelam hydrochloride) to stable ... - Medical News Today

Genzyme Reports Financial Results for the First Quarter of 2006  Apr 19, 2006
...revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol(R) (colesevelam hydrochloride) -- was up 21 ... - MSN Money

Genzyme Reports Financial Results for the First Quarter of 2006  Apr 19, 2006
Other revenue -- including oncology revenue, sales of pharmaceutical intermediates, and royalties from sales of WelChol® (colesevelam hydrochloride) -- was up ... - Yahoo! News



Genzyme Reports 22 Percent Increase in Fourth-Quarter Revenue  Jan 9, 2006
...oncology revenue, sales of pharmaceutical intermediates, R&D revenue, and royalties from the sale of WelChol(R) (colesevelam hydrochloride) -- was $39 million ... - MSN Money

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional